Summary
- Profile Type
- Technology offer
- POD Reference
- TODE20240710009
- Term of Validity
- 21 August 2024 - 21 August 2025
- Company's Country
- Germany
- Type of partnership
- Research and development cooperation agreement
- Targeted Countries
- All countries
Contact the EEN partner nearest to you for more information.
Find my local partner
General information
- Short Summary
- As a German diagnostics and biotechnology research campus, the public-private partnership is breaking new ground in infection diagnostics. Partners from science, medicine and industry are jointly developing novel solutions for fast and cost-effective on-site diagnostics of infections. Focused on detecting infectious agents and their antimicrobial resistance (AMR) using photonic, microfluidic and molecular methods. The campus is searching partner for technical and research cooperation agreements
- Full Description
-
Infectious diseases are a major burden to public health and the global economy, not in the last due to antimicrobial resistance (AMR). Rapid Point-of-Care-Tests (POCT) for in vitro diagnostics (IVD) are key tools in the effective management of patients with infections with an as yet large unmet clinical need in human and veterinary medicine. The German cluster with its unique cooperation between public and private partners on an equal footing is breaking down barriers to the establishment of new diagnostics. Promising solutions from basic research are thus brought more quickly into the diagnostic routine in the form of market-ready products and thus to users and patients.
In a triad of technology, application and production, more than 30 partners from science, medicine and industry are developing in this innovation hub marketable solutions for rapid and cost-effective decentral and lab-based analysis of infections – in human medicine, animal diseases and pathogen detection in food or water.
Innovative photonic and molecular biological methods are developed and combined to reliably detect infectious diseases (especially viruses, bacteria and fungi) and antimicrobial resistance (AMR) and to better understand the host response (e.g. in sepsis).
On the research campus, the partners cooperate along the value chain. Therefore, potential partners in the field of infection research are invited to collaborate. Applied research projects are addressed as well as technology and product development for diagnostic solutions. Thus partners from research, biotech, medical labs and life science industry are welcome.
Under technology cooperation agreements partners are sought for:
- Diagnostic technology development and validation
- Diagnostics product development collaborations
Under research cooperation agreements partners are sought for:
- Joint R&D projects under EU and other funding schemes such as the coming Horizon Europe in the field of infection research and diagnostics - Advantages and Innovations
-
- Joint research can be performed under one roof in well-equipped labs with excellent infrastructure
- Optimal networking for campus partners in a triad of technology, medical application and industry
- Broadening the technology competence: Integration of the latest findings from academic research
- Close contact to clinical experts and access to clinical samples
- Access to state-of-art research infrastructure (photonics, molecular and microbiology)
The close collaboration and the integration of all relevant partners right from the beginning shortens development time of innovative diagnostic products significantly. - Stage of Development
- Concept stage
- Sustainable Development Goals
- Goal 3: Good Health and Well-being
- IPR status
- No IPR applied
Partner Sought
- Expected Role of a Partner
-
Partners are sought from research, biotech/medical labs and life science industry for cooperation agreements as follows:
Technical cooperation agreements:
- Medical diagnostic technology development and validation
- Medical diagnostics product development collaborations
Research cooperation agreements:
Joint R&D projects under EU and other funding schemes such as the coming Horizon Europe in the field of infection research and medical diagnostics - Type and Size of Partner
- SME <=10
- SME 11-49
- R&D Institution
- SME 50 - 249
- Big company
- University
- Other
- Type of partnership
- Research and development cooperation agreement
Dissemination
- Technology keywords
- 010002009 - Water Pollution / Treatment
- 06001018 - Virus, Virology/Antibiotics/Bacteriology
- 10004003 - Wastewater Recycling
- 06001005 - Diagnostics, Diagnosis
- 06003001 - Bioinformatics
- Market keywords
- 05001007 - Other diagnostic
- 04014 - Bioinformatics
- 05001001 - Diagnostic services
- 05001002 - In-vitro diagnostics
- 09008002 - Water, sewerage, chemical and solid waste treatment plants
- Sector Groups Involved
- Health
- Targeted countries
- All countries